In this episode Dr. Ladd McNamara discusses more of the side effects of the usage of Cholesterol-Lowering Statin Drugs.
- Chapter 25: Statin Drugs May Cause Depression and Possibly Suicide
- Chapter 26: Statin Drugs Impair Memory and the Ability to Think
- Chapter 27: Statin Drugs may Cause Cancer
Chapter Excerpts by Ladd McNamara, M.D.
Fifteen percent of those taking statin drugs develop some cognitive side effects.
Dr. Ladd McNamara is concerned that the pharmaceutical industry denies that statin drugs can cause amnesia; yet in many of their own studies, memory loss was reported.
Over 5 years, of the approximately 250 women taking Lipitor®, there were 12 new cases of breast cancers, compared to one new case among the placebo group. Certainly not proof that statin drugs cause breast cancer, but a 1500% increase risk of breast cancer is enough"smoke" to be worried about a fire.
Because Co-Q10 levels are decreased by statin drugs, it is easy for Dr. Ladd McNamara to predict that we will see an increased risk of prostate and breast cancer as a result.
Chapter References by Ladd McNamara, M.D.
- 43: King D, Wilburn A, Wofford M, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 2003 Dec; 23(12):1663-1667.
- 44: Muldoon M, Barger S, Ryan C, Flory J, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med. 2000 May; 108(7):538-546.
- 45: Eleanor Laise. The Lipitor Dilemma, Smart Money: The Wall Street Journal Magazine of Personal Business, November 2003.
- 46: Duane Graveline, MD., Lipitor: Thief of Memory, 2004, www.buybooksontheweb.com.
- 47: Lopena O, Pharm D, Pfizer, Inc., written communication, 2002. Quoted in an email communication from Duane Graveline, spacedoc@webtv.net.
- 48: Leung, B, Sattar N, Crilly A, et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003 170:1524-1530.
- 49: Palinski, W, et al. Immunomodulation: a new role for statins? Nature Medicine, 2000 Dec 6(12):1311-1312.
- 50: Newman T, Hulley S. Carcinogenicity of lipid-lowering drugs. JAMA 1996 Jan 3; 275(1):55-60.
- 51: Folkers K, et al. Activities of Vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun. 1997 234(2):296-299.
- 52: Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Commun, 1995 Jul 6; 212(1):172-7.
- 53: Sacks F, Pfeffer M, Moye L, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996 Oct 3; 335(14):1001-1009.
- 54: Boudreau D, Gardner J, Malone K, et al. The association between 3-hydroxy-3-methylglutaryl co-enzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. Cancer 2004 Jun 1; 100(11):2308-2316.
- 55: Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002 Jul 6; 360(9326):7-22.
Podcast: Play in new window | Download